(VPH: CSE) (VPHIF: OTCQB) (VP2: FSE)
Why Valeo Pharma?
SPONSOR: PlantX (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF) is the one-stop-shop for everything Plant-Based.
Burger King is launching a new vegan burger in the UK next week (11th January).
The new vegan burger comes a year after the chain released its plant-based Rebel Whopper, which was unsuitable for vegans because of it being cooked on the same grill as meat.
However, this time the US fast-food giant will sell a 100% vegan bean burger, which includes two signature veggie patties on a toasted sesame bun, topped with fresh-cut lettuce, juicy tomatoes, ketchup, and vegan mayo.
The burger is said to cost around £4.59 on its own, or £5.59 with a drink.
The Rebel Whopper
Last year, the chain launched a Rebel Whopper for Veganuary, angering many vegans because it was grilled on the same surface as the meat version.
It however said at the time that the burger was aimed at ‘flexitarians’.
Commenting on the plant-based Whopper, Toni Vernelli, international head of marketing at Veganuary, said: “For all of the important issues that Veganuary – and most vegans – are trying to address through their food choices it makes absolutely no difference whether the plant-based patty is cooked separately or on the same grill as the meat.
“What does make a big difference to animals and the planet is when non-vegans choose a plant-based menu option, enjoy it and then order it again.
“And that’s exactly who Burger King’s plant-based Whopper is aimed at, flexitarians who want to reduce their meat consumption for health or environmental reasons, or are considering going vegan.”
Veganuary launches
Burger King has joined a slew of retailers, restaurants, and fast-food chains that have launched new products for Veganaury this year.
Wagamama is moving ahead with a new vegan-themed menu for Veganuary amid its pledge to make 50% of its menu meat-free by the end of 2021.
The new menu offers plant-based versions of cult favourite dishes; Chilli Squid, sticky ribs, Firecracker Curry, and Grilled Duck Donburi, which the company hopes will entice even their ‘most set-in-their-ways meat-eating fans’.
Pret A Manger is adding nine new vegan items including breakfast items and wraps to its January menu, which will be launched at both Pret and Veggie Pret outlets nationwide.
Sandwich chain Subway has launched the vegan T.L.C. (Tastes Like Chicken) Sub and Vegan Double Choc Cookie, both of which are available to order in Subway stores just in time for Veganuary.
Source: https://www.totallyveganbuzz.com/news/burger-king-vegan-burger-veganuary/
Draganfly to Showcase its Health Security and Telehealth Technologies
Los Angeles, CA, Jan. 07, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce that it will be attending this year’s Consumer and Electronics Show taking place virtually January 11-14, 2021.
Draganfly will be featuring its Vital Intelligence system which can enable existing camera systems or cameras on kiosks, drones, tables and smartphones to measure vital signs as well as its Varigard 24hr pathogen sequestration and kill sanitizing spray applied via patented drone.
“We are very proud to be bringing Draganfly to CES this year,” said Cameron Chell, CEO of Draganfly. “CES is rooted in technology innovation. Draganfly is excited to showcase our innovations which we rolled out through the National Safely Opening Site and National Safely Opening Schools COVID-19 safety protocol. This included the development of our Vital Intelligence health-tech, our drone vaccination delivery and our 24-hour sequestration sanitizer delivered to stadiums, arenas, malls and conference centers delivered by drone.”
Draganfly will provide a live demo of its Vital Intelligence technology on January 13, 2021 at 130PM PST/430PM EST. Click here to register.
VANCOUVER, BC and ERIE, Pa. , Jan. 7, 2021 – Imagine AR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables sports teams, businesses, and organizations to create instant AR engagement and activation global campaigns without a technical background, is pleased to announce it is one of six global companies featured in the GSIC White Paper augmented reality fan engagement case study to be published and formally presented on January 19, 2021 . ImagineAR CEO Alen Paul Silverrstieen will be a panelist on the global webcast presentation.
The “Next-Generation Fan Engagement: The Coming Together of Content, Commercial, Code & The Consumer” by GSIC (powered by Microsoft), white paper is divided into two parts – the first half details how the historical business model of Sport is gradually eroding due to the fragmentation of audiences due to the proliferation of smart phones and 4G data connectivity. The second half details innovative fan engagement solutions that deliver commercial and strategic benefits by using next- generation technologies such as augmented reality, computer vision & blockchain.
The ImagineAR case study features the Louisville Bats baseball team, Cincinnati Reds Triple-A Affiliate, Restaurant Augmented Reality Mascot Partnership Program from early 2020. Click to learn more .
ImagineAR CEO, Alen Paul Silverrstieen said “The GSIC, powered by Microsoft, is a highly respected global organization consulting with many of the leading sports organizations and teams. We are honored to be included as a mobile augmented reality case study in this new white paper. It will further enhance our status as a leader in sports fan engagement using AR and create new global sales opportunities.”
Toronto, Ontario–(January 7, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce today that it has entered into a binding Letter of Intent (the “LOI“) to acquire 100% of Concierge Medical Consultant Inc. (“Concierge“), an arm’s length private telehealth and medical concierge services company, incorporated under the laws of British Columbia (the “Transaction”).
Subject to the completion of satisfactory due diligence by both Datametrex and Concierge, under the terms and conditions of the LOI, Datametrex and Concierge will enter into a Definitive Agreement (the “Definitive Agreement“) on or about January 20, 2021.
The Company believes that in the current pandemic environment that there is a likely increase in mental health issues in society attributed to periods of extended isolation and related the disruption of social interaction. Accordingly, management of the Company feel that there is a significant need in the market place for provide personal health solutions and the Company recognizes telehealth and concierge medical service as a part of solution to this growing problem.
“We strongly believe that there is a growing need for remote health and wellness solutions as a result of the pandemic. The lockdowns and the isolation that Canadians have endured this past year have only increased the need for mental and physical health solutions. By providing Telehealth solutions we are able to keep people out of the already overwhelmed hospital infrastructure while at the same time providing Canadians with professional advice and care that they need and deserve.”, said Andrew Ryu, the Company’s Chairman.
Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas,TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and colleges
VANCOUVER, BC / January 7, 2021 / EMPOWER CLINICS INC. (CBDT:CSE)(8EC:Frankfurt)(EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce the successful launch of our KAI Saliva PCR Test (“KAI Saliva”) with our initial soft launch of 5,000 units sold out and the order of 25,000 additional units with a sales value of approximately $5,500,000.
INITIAL DEMAND FOR FIRST RUN KAI SALIVA CAME FROM EXISTING COMMERCIAL CUSTOMERS, INCLUDING FILM & TELEVISION PRODUCTIONS. DIRECT TO CONSUMER CHANNEL LAUNCH IMMINENT
Initial and overwhelming demand for KAI Saliva stemmed from our existing customers in film & television productions, the commercial sector, and concierge testing supported by Sun Valley Health in Arizona. Given the early and significant success of KAI Saliva since its launch on December 15, 2020, Empower is extremely confident in the continued success of KAI Saliva with both existing and expanded commercial customers in this next run.
Los Angeles, CA, Jan. 06, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce the awarding of a new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.
The design is ideal for Beyond Visual Line of Sight (BVLOS) and for transporting goods in hard to reach areas or flight over people at night.
US Patent No. 10,807,707 is an unmanned aircraft system (UAS) configured for both vertical take-off and landing (VTOL) and fixed-wing flight operations includes forward, and aft wing assemblies mounted to the fuselage, each wing assembly including port and starboard nacelles terminating in motor-driven rotors powered by an onboard control system capable of adjusting rotor speeds.
TORONTO, Jan. 06, 2021 — Avicanna Inc. (“ Avicanna ” or the “ Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that the Company has entered into a master services agreement (the “ Master Services Agreement ” ) with the University Health Network (“ UHN ”) for projects to be performed by Dr. Peter Carlen as the principal investigator related to epilepsy. Additionally, the company has completed the technical transfer and first pharmaceutical pilot production of its epilepsy drug candidate at Altea Farmaceutica S.A. (“ Altea ”) in Bogota, Colombia, a major step required for the final preparation for its registration and commercialization in South America.
Toronto, Ontario–(January 6, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce the Company has launched as of January 4, 2021, a Concierge Covid-19 testing service for the travelling public in both Toronto and Vancouver.
Fabled Silver Gold Corp. (TSXV: FCO) (FSE: 7NQ) (“Fabled” or the “Company“) is pleased to announce the completion of the first ever follow up ground sampling program to evaluate the IP geophysical anomalies on the Santa Maria Property in Parral, Mexico. Fabled is also pleased to provide an update on progress made on its initial 8,000 meter drill program.
Peter J. Hawley, CEO and President, remarks, “The results of the follow up sampling of the IP anomalies have provided favorable silver results over all on anomalies sampled, of which certain results were a pleasant confirmation of not only the location of the IP anomaly but also exhibiting silver grades on surface even though the anomaly is at depth. It is not common to sample almost one ounce of silver over a buried IP Anomaly.”
Of particular interest are two areas to the west and outside the new resource area. The first is anomaly IPSM-10 at the western sector of the property, where sample #816013 reported 29.8 g/t Ag. The anomaly is thought to represent the intersection of the northeast trending Peneto Vein located to the south west of the property and the intersection of the Santa Maria vein structures. Geophysical interpretation suggests it represents a shallow, thin body (“vein type”) response.
The second is located between IPSM-10 and the new resource trend and identified by IP anomaly IPSM-12 and sample #816007 which reported 14.2 g/t Ag and is thought to be the contact between the Santa Maria Vein trends and a felsic mineralized dike contact. Geophysical interpretation suggests a deep seated (>100 m) vein type response.
A total of 11 first priority IP targets have been delineated property wide (see Figure 1 below), which are in a generalized east – west direction. The geological team collected a total of 26 surface samples over all anomalies and nearby areas.
Figure 1: IP Anomalies on the Santa Maria Property with surface sample assay values and locations.
Drilling Update
The Company has completed two drill holes SM20-01 – 02 for a total of 396 metres. Holes 01 and 02 have been sampled and submitted to ALS Chihuahua Laboratory for analysis. Hole SM 20-03 is in progress. The focus of the program is to determine the true potential of the property, which is expected to take several months to complete.
Option Grants
Fabled also is pleased to announce that pursuant to its stock option plan it has granted 200,000 stock options to a consultant for the Company, each exercisable to acquire one common share of Fabled at an exercise price of $0.10 per common share until January 06, 2031. The stock options vest as to 25% on the date of grant, and as to 25% every 6 months until fully vested.
QA QC Procedure
Analytical results of sampling reported by Fabled Silver Gold represent surface rock samples submitted by Fabled Silver Gold staff directly to ALS Chemex, Chihuahua, Chihuahua, Mexico. Samples were crushed, split, and pulverized as per ALS Chemex method PREP-31, then analyzed for ME-ICP61 33 element package by four acid digestion with ICP-AES Finish. ME-GRA21 method for Au and Ag by fire assay and gravimetric finish, 30g nominal sample weight.
Over Limit Methods
For samples triggering precious metal over-limit thresholds of 10g/t Au or 200g/t Ag, the following is being used:
Au-GRA21 Au by fire assay and gravimetric finish with 30g sample.
Ag-GRA21 Ag by fire assay and gravimetric finish.
Fabled Silver Gold monitors QA/QC using commercially sourced standards and locally sourced blank materials inserted within the sample sequence at regular intervals.
About Fabled Silver Gold Corp.
Fabled is focused on acquiring, exploring and operating properties that yield near-term metal production. The Company has an experienced management team with multiple years of involvement in mining and exploration in Mexico. The Company’s mandate is to focus on acquiring precious metal properties in Mexico with blue-sky exploration potential.
The Company has entered into an agreement with Golden Minerals Company to acquire the Santa Maria project, a high-grade silver-gold property situated in the center of the Mexican epithermal silver-gold belt. The belt has been recognized as a significant metallogenic province, which has reportedly produced more silver than any other equivalent area in the world.
For further information please contact:
Mr. Peter J. Hawley, President and C.E.O.
Fabled Silver Gold Corp.
Phone: (819) 316-0919
[email protected]